Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Booster Bookings Boom As One Million Book Life-Saving Jab in Three Days
More than one million booster jabs have been booked in the last three days as […]
£3 Million More to Reduce Brain Injuries at Birth
NHS maternity staff will benefit from a further £3 million to improve the safety of […]
First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
Walk-in Sites Open Up For People To Get Covid-19 Booster Jab
Hundreds of walk-in sites across the country are now offering booster vaccines as the NHS […]
UK Government Secures Groundbreaking COVID-19 Antivirals
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government […]
New Technique Makes Heart Transplant Possible for More Children in Need
A new technique developed by researchers BHF funded at Great Ormond Street Hospital for Children […]
NHS Mental Health Job Coaches Help Thousands Find Work
Thousands of people with mental health problems have been supported into employment during the pandemic, […]
NHS Announces Deal for Life Changing Sickle Cell Treatment
The first treatment for sickle cell disease in over 20 years will be rolled out […]
NHS Sets Out Next Stage of Covid Recovery Plan
Guidance to support hospitals with covid recovery over the next six months has been set […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more